Federal Data Hub › HRSA 340B · JSON
METROPOLITAN FAMILY HEALTH NETWORK · 340B ID CH0217710
ParticipatingChildren's Hospital
METROPOLITAN FAMILY HEALTH NETWORK INC. is a Children's Hospital enrolled in the federal 340B Drug Pricing Program in Jersey City, NJ. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 19 contract-pharmacy arrangement(s) (18 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| DUANE READE | JERSEY CITY, NJ | 2016-01-01 | — | 16805 |
| DUANE READE | JERSEY CITY, NJ | 2012-01-18 | — | 9433 |
| DUANE READE PHCY. DEPT. | JERSEY CITY, NJ | 2012-01-18 | — | 9311 |
| GARFIELD HEALTHCARE PHARMACY | JERSEY CITY, NJ | 2016-10-01 | — | 105627 |
| MEDLY PHARMACY | JERSEY CITY, NJ | 2022-07-01 | — | 131949 |
| MEDLY PHARMACY | SOMERVILLE, NJ | 2019-10-01 | — | 18324 |
| RELIANT CARE SOLUTIONS | FEASTERVILLE TREVOSE, PA | 2021-01-01 | — | 92644 |
| WALGREEN EASTERN CO INC | BAYONNE, NJ | 2012-01-18 | — | 4078 |
| WALGREEN EASTERN CO., INC. | BAYONNE, NJ | 2022-01-01 | — | 94539 |
| WALGREEN EASTERN CO., INC. | EAST ORANGE, NJ | 2012-01-18 | — | 4077 |
| WALGREEN EASTERN CO., INC. | HOBOKEN, NJ | 2012-01-18 | 2023-11-07 | 4081 |
| WALGREEN EASTERN CO., INC. | JERSEY CITY, NJ | 2012-01-18 | — | 9376 |
| WALGREEN EASTERN CO., INC. | JERSEY CITY, NJ | 2012-01-18 | — | 9346 |
| WALGREEN EASTERN CO., INC. | JERSEY CITY, NJ | 2022-01-01 | — | 116003 |
| WALGREEN EASTERN CO., INC. | UNION CITY, NJ | 2013-10-01 | — | 16613 |
| WALGREEN EASTERN CO., INC. | UNION CITY, NJ | 2012-01-18 | — | 9398 |
| WALGREEN EASTERN CO., INC. | WEST NEW YORK, NJ | 2012-01-18 | — | 4076 |
| WALGREEN EASTERN CO., INC. | WEST NEW YORK, NJ | 2022-01-01 | — | 115995 |
| WALGREENS MAIL SERVICE, INC. | TEMPE, AZ | 2013-10-01 | — | 6207 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.